NCT06882733

Brief Summary

This study aims to evaluate the immediate hemodynamic effects of transcutaneous electrical nerve stimulation (TENS) on the popliteal artery and vein. Vascular issues like PAOD and DVT are common in patients with diabetes, obesity, or immobility due to increased resistance and reduced blood flow. Traditional treatments (medication or surgery) are not always feasible, prompting interest in TENS as an alternative. Although primarily used for pain relief, TENS may enhance blood flow. This research compares different stimulation frequencies (80 Hz vs. 4 Hz) and sites (gastrocnemius muscle vs. thoracolumbar sympathetic ganglia) to identify the most effective configuration.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 3, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 18, 2025

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

July 18, 2025

Status Verified

July 1, 2025

Enrollment Period

4 months

First QC Date

March 12, 2025

Last Update Submit

July 16, 2025

Conditions

Keywords

transcutaneous electrical nerve stimulation (TENS)blood flowsympathetic ganglia

Outcome Measures

Primary Outcomes (1)

  • Doppler ultrasound measurement of changes in popliteal fossa blood flow

    Using Doppler ultrasound to measure blood flow before, during, immediately after, and 15 minutes after electrical stimulation to observe the effects of electrical stimulation on blood flow.

    45 minutes

Secondary Outcomes (1)

  • heart rate

    45 minutes

Study Arms (4)

Sympathetic Ganglia with Low-Frequency Electrical Stimulation

EXPERIMENTAL

Sympathetic Ganglia (T12.L1.L2) Low-Frequency Electrical Stimulation (4Hz) electrical stimulation:15-minute

Device: Transcutaneous Electrical Nerve Stimulation,TENS

Sympathetic Ganglia with High-Frequency Electrical Stimulation

EXPERIMENTAL

Sympathetic Ganglia (T12.L1.L2) Low-Frequency Electrical Stimulation (80Hz) electrical stimulation:15-minute

Device: Transcutaneous Electrical Nerve Stimulation,TENS

gastrocnemius with Low-Frequency Electrical Stimulation

EXPERIMENTAL

gastrocnemius with Low-Frequency Electrical Stimulation Low-Frequency (4Hz) electrical stimulation:15-minute

Device: Transcutaneous Electrical Nerve Stimulation,TENS

gastrocnemius with high-Frequency Electrical Stimulation

EXPERIMENTAL

gastrocnemius with high-Frequency Electrical Stimulation high-Frequency(80Hz) electrical stimulation:15-minute

Device: Transcutaneous Electrical Nerve Stimulation,TENS

Interventions

low frequency (4Hz) and sympathetic ganglion(T12.L1.L2) low frequency (4Hz) and gastrocnemius high frequency (80Hz) and sympathetic ganglion(T12.L1.L2) high frequency (80Hz) and gastrocnemius

Sympathetic Ganglia with High-Frequency Electrical StimulationSympathetic Ganglia with Low-Frequency Electrical Stimulationgastrocnemius with Low-Frequency Electrical Stimulationgastrocnemius with high-Frequency Electrical Stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy people
  • Age: 18 years and above (inclusive)
  • Body mass index (BMI) between 18.5 and 24

You may not qualify if:

  • Unable to complete two interventions within a week
  • Have contraindications to electrotherapy (for example: metal implants in the body, open wounds, pregnancy, sensory loss)
  • Obvious varicose veins 4. Unable to lie down for about 1 to 2 hours 5. Taking drugs or nutritional supplements that affect autonomic nervous activity or vasodilation (for example: Ginkgo biloba) 6. Smoking 7. Ankle and Ankle Index (ABI) less than 0.9 or greater than 1.3

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Medical University

Kaohsiung City, Taiwan, 807378, Taiwan

RECRUITING

MeSH Terms

Interventions

Transcutaneous Electric Nerve Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
graduate student

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 18, 2025

Study Start

December 3, 2024

Primary Completion

March 30, 2025

Study Completion

December 1, 2025

Last Updated

July 18, 2025

Record last verified: 2025-07

Locations